The financial toxicity of multiple sclerosis
ResearchPod
English - November 17, 2021 09:00 - 13 minutes - 9.48 MBScience Technology science research outreach education stem learning academic technology impact scicomm Homepage Download Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: Effects of training on blood brain flow
Multiple sclerosis (MS) is a neurologic autoimmune disease that is a lifelong condition with high medical costs. As a result, many patients do not adhere to treatment plan, which further reduces their quality of life. There are also non-medical costs to consider, such as loss of productivity at work and early retirement.
Research led by Professor Carl Asche, at the University of Illinois, explores the financial burdens and advocates for improved strategies to reduce the cost burden of the disease.
Read more in Research Outreach
Read the original article: https://doi.org/10.18553/jmcp.2010.16.9.703